Primary Site >> Biliary tract Cancer

Gene >> CA9

Journal: Cancer Biother Radiopharm. 2006 Jun;21(3):263-8.
Title: Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250.
Author: Hendrickx, Baudewijn W|Punt, Cees J A|Boerman, Otto C|Postema, Ernst J|Oosterwijk, Egbert|Mavridu, Agapi|Corstens, Frans H M|Oyen, Wim J G
PMID: 16918303
Journal: Eur J Surg Oncol. 2011 Jan;37(1):80-6.
Title: The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder.
Author: Sergeant, G|Lerut, E|Ectors, N|Hendrickx, T|Aerts, R|Topal, B
PMID: 21109386
Journal: Am J Clin Pathol. 2014 Feb;141(2):219-25.
Title: Immunohistochemical reevaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues.
Author: Luong-Player, Adelina|Liu, Haiyan|Wang, Hanlin L|Lin, Fan
PMID: 24436269
Journal: Int J Clin Exp Pathol. 2015 Jan 1;8(1):862-6. eCollection 2015.
Title: CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
Author: Gu, Mijin
PMID: 25755787
Journal: PLoS One. 2015 Jul 24;10(7):e0132953.
Title: Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.
Author: Sadot, Eran|Simpson, Amber L|Do, Richard K G|Gonen, Mithat|Shia, Jinru|Allen, Peter J|D'Angelica, Michael I|DeMatteo, Ronald P|Kingham, T Peter|Jarnagin, William R
PMID: 26207380